Published in Front Aging Neurosci on July 07, 2014
Cerebral blood flow measured by arterial spin labeling MRI as a preclinical marker of Alzheimer's disease. J Alzheimers Dis (2014) 0.96
Detection of subjects and brain regions related to Alzheimer's disease using 3D MRI scans based on eigenbrain and machine learning. Front Comput Neurosci (2015) 0.92
Detection of Alzheimer's disease by displacement field and machine learning. PeerJ (2015) 0.81
The Utility of Cerebral Blood Flow as a Biomarker of Preclinical Alzheimer's Disease. Cell Mol Neurobiol (2016) 0.77
Bipolar Patients with Vascular Risk Display a Steeper Age-Related Negative Slope in Inhibitory Performance but Not Processing Speed: A Preliminary Study. Am J Geriatr Psychiatry (2016) 0.77
Cerebral Blood Flow Alterations as Assessed by 3D ASL in Cognitive Impairment in Patients with Subcortical Vascular Cognitive Impairment: A Marker for Disease Severity. Front Aging Neurosci (2016) 0.76
Editorial: Neuropsychology and Neuropsychiatry of Neurodegenerative Disorders. Front Aging Neurosci (2015) 0.75
Dynamic association between perfusion and white matter integrity across time since injury in Veterans with history of TBI. Neuroimage Clin (2016) 0.75
The Role of Cardiovascular Risk Factors and Stroke in Familial Alzheimer Disease. JAMA Neurol (2016) 0.75
Cerebral Blood Flow and Amyloid-β Interact to Affect Memory Performance in Cognitively Normal Older Adults. Front Aging Neurosci (2017) 0.75
Higher Brain Perfusion May Not Support Memory Functions in Cognitively Normal Carriers of the ApoE ε4 Allele Compared to Non-Carriers. Front Aging Neurosci (2016) 0.75
AFNI: software for analysis and visualization of functional magnetic resonance neuroimages. Comput Biomed Res (1996) 53.52
Advances in functional and structural MR image analysis and implementation as FSL. Neuroimage (2004) 49.54
Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol (1991) 49.03
SENSE: sensitivity encoding for fast MRI. Magn Reson Med (1999) 29.55
Segmentation of brain MR images through a hidden Markov random field model and the expectation-maximization algorithm. IEEE Trans Med Imaging (2001) 25.22
Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the american heart association/american stroke association. Stroke (2011) 10.11
Frequent amyloid deposition without significant cognitive impairment among the elderly. Arch Neurol (2008) 7.95
Imaging beta-amyloid burden in aging and dementia. Neurology (2007) 7.70
Age, neuropathology, and dementia. N Engl J Med (2009) 6.36
Magnetic resonance image tissue classification using a partial volume model. Neuroimage (2001) 5.87
Stroke risk profile: adjustment for antihypertensive medication. The Framingham Study. Stroke (1994) 5.83
Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges. Lancet Neurol (2010) 5.76
Neurovascular pathways to neurodegeneration in Alzheimer's disease and other disorders. Nat Rev Neurosci (2011) 5.64
Midlife cardiovascular risk factors and risk of dementia in late life. Neurology (2005) 5.12
Selective aging of the human cerebral cortex observed in vivo: differential vulnerability of the prefrontal gray matter. Cereb Cortex (1997) 4.87
Quantification of relative cerebral blood flow change by flow-sensitive alternating inversion recovery (FAIR) technique: application to functional mapping. Magn Reson Med (1995) 4.56
The age-dependent relation of blood pressure to cognitive function and dementia. Lancet Neurol (2005) 4.54
Prevalence of cerebral white matter lesions in elderly people: a population based magnetic resonance imaging study. The Rotterdam Scan Study. J Neurol Neurosurg Psychiatry (2001) 4.51
Aggregation of vascular risk factors and risk of incident Alzheimer disease. Neurology (2005) 4.04
Cerebral blood flow, blood volume and oxygen utilization. Normal values and effect of age. Brain (1990) 3.54
Magnetic resonance perfusion imaging in acute ischemic stroke using continuous arterial spin labeling. Stroke (2000) 3.44
Pattern of cerebral hypoperfusion in Alzheimer disease and mild cognitive impairment measured with arterial spin-labeling MR imaging: initial experience. Radiology (2005) 3.14
The role of metabolic disorders in Alzheimer disease and vascular dementia: two roads converged. Arch Neurol (2009) 3.13
Longitudinal changes in cerebral blood flow in the older hypertensive brain. Stroke (2007) 2.75
Normal cerebral perfusion measurements using arterial spin labeling: reproducibility, stability, and age and gender effects. Magn Reson Med (2004) 2.71
Mild cognitive impairment and alzheimer disease: patterns of altered cerebral blood flow at MR imaging. Radiology (2009) 2.70
Abeta deposits in older non-demented individuals with cognitive decline are indicative of preclinical Alzheimer's disease. Neuropsychologia (2008) 2.58
A signal processing model for arterial spin labeling functional MRI. Neuroimage (2005) 2.41
Assessment of cerebral blood flow in Alzheimer's disease by spin-labeled magnetic resonance imaging. Ann Neurol (2000) 2.35
Regional rates of neocortical atrophy from normal aging to early Alzheimer disease. Neurology (2009) 2.18
Cerebrovascular disease and threshold for dementia in the early stages of Alzheimer's disease. Lancet (1999) 2.11
Quantitative evaluation of automated skull-stripping methods applied to contemporary and legacy images: effects of diagnosis, bias correction, and slice location. Hum Brain Mapp (2006) 2.06
Perfusion magnetic resonance imaging with continuous arterial spin labeling: methods and clinical applications in the central nervous system. Eur J Radiol (1999) 1.94
A theoretical and experimental comparison of continuous and pulsed arterial spin labeling techniques for quantitative perfusion imaging. Magn Reson Med (1998) 1.93
Development of Alzheimer-related neurofibrillary changes in the neocortex inversely recapitulates cortical myelogenesis. Acta Neuropathol (1996) 1.83
Cerebral perfusion and oxygenation differences in Alzheimer's disease risk. Neurobiol Aging (2008) 1.82
In vivo method for correcting transmit/receive nonuniformities with phased array coils. Magn Reson Med (2005) 1.72
Dissociation of neuropathology from severity of dementia in late-onset Alzheimer disease. Neurology (2006) 1.68
BOLD and perfusion response to finger-thumb apposition after acetazolamide administration: differential relationship to global perfusion. J Cereb Blood Flow Metab (2003) 1.62
Prevalence of dementia disorders in the oldest-old: an autopsy study. Acta Neuropathol (2010) 1.60
Distinct profiles of brain and cognitive changes in the very old with Alzheimer disease. Neurology (2011) 1.60
Cardiovascular risk factors promote brain hypoperfusion leading to cognitive decline and dementia. Cardiovasc Psychiatry Neurol (2012) 1.57
Vascular risk factors and Alzheimer's disease: are these risk factors for plaques and tangles or for concomitant vascular pathology that increases the likelihood of dementia? An evidence-based review. Alzheimers Res Ther (2012) 1.30
Volume of white matter hyperintensities in healthy adults: contribution of age, vascular risk factors, and inflammation-related genetic variants. Biochim Biophys Acta (2011) 1.29
A rapid and sensitive PCR strategy employed for amplification and sequencing of porA from a single colony-forming unit of Neisseria meningitidis. Gene (1993) 1.24
Hypertension and longitudinal changes in cerebral blood flow: the SMART-MR study. Ann Neurol (2012) 1.21
The vascular contribution to Alzheimer's disease. Clin Sci (Lond) (2010) 1.21
Cerebral hemodynamics and vascular risk factors: setting the stage for Alzheimer's disease. J Alzheimers Dis (2012) 1.21
Coronary risk correlates with cerebral amyloid deposition. Neurobiol Aging (2011) 1.17
Clustering of cardiovascular risk factors: targeting high-risk individuals. Am J Cardiol (1995) 1.16
Cerebral blood flow and BOLD responses to a memory encoding task: a comparison between healthy young and elderly adults. Neuroimage (2007) 1.15
Regional white matter pathology in mild cognitive impairment: differential influence of lesion type on neuropsychological functioning. Stroke (2008) 1.09
Differential age effects on cerebral blood flow and BOLD response to encoding: associations with cognition and stroke risk. Neurobiol Aging (2007) 1.06
Effect of mild cognitive impairment and APOE genotype on resting cerebral blood flow and its association with cognition. J Cereb Blood Flow Metab (2012) 1.05
Coronary artery disease is associated with cognitive decline independent of changes on magnetic resonance imaging in cognitively normal elderly adults. J Am Geriatr Soc (2012) 1.01
Interaction of age and APOE genotype on cerebral blood flow at rest. J Alzheimers Dis (2013) 1.00
Framingham cardiovascular risk profile correlates with impaired hippocampal and cortical vasoreactivity to hypercapnia. J Cereb Blood Flow Metab (2010) 0.97
Assessment of Alzheimer's disease risk with functional magnetic resonance imaging: an arterial spin labeling study. J Alzheimers Dis (2012) 0.96
Preventing Alzheimer's disease by targeting vascular risk factors: hope and gap. J Alzheimers Dis (2012) 0.94
Age dependence of the flow velocity in the basal cerebral arteries--a transcranial Doppler ultrasound study. Ultrasound Med Biol (1988) 0.93
Aggregate effects of vascular risk factors on cerebrovascular changes in autopsy-confirmed Alzheimer's disease. Alzheimers Dement (2014) 0.92
Vascular health risks and fMRI activation during a memory task in older adults. Neurobiol Aging (2008) 0.85
Baseline cardiovascular risk predicts subsequent changes in resting brain function. Stroke (2012) 0.85
The evidence for treating hypertension in older people with dementia: a systematic review. J Hum Hypertens (2013) 0.80
Low cerebral blood flow velocity and risk of white matter hyperintensities. Ann Neurol (2001) 0.79
The effects of nicotine and cannabis co-use during adolescence and young adulthood on white matter cerebral blood flow estimates. Psychopharmacology (Berl) (2020) 0.75
Circadian alterations during early stages of Alzheimer's disease are associated with aberrant cycles of DNA methylation in BMAL1. Alzheimers Dement (2016) 0.75
The effect of interference on temporal order memory in individuals with Parkinson's disease. Brain Cogn (2016) 0.75